Schizophrenia and Alcohol Use Disorder
Clinical research in schizophrenia with co-occurring alcohol use disorder includes studies focused on reducing alcohol intake and addressing dual-diagnosis care in psychiatric populations.
- Alcohol consumption in schizophrenia
- Dual-diagnosis psychiatric care
- Substance use in severe mental illness
These trials reflect interest in the overlap between psychotic disorders and harmful alcohol use within specialist psychiatric services.
Metabolic Health in Psychiatric Disorders
Research also addresses metabolic state in people with schizophrenia, particularly those receiving treatment associated with higher cardiometabolic risk and living with prediabetes or diabetes.
- Metabolic complications in schizophrenia
- Prediabetes and diabetes
- Cardiometabolic monitoring
The therapeutic focus includes managing physical health concerns alongside long-term psychiatric treatment.
Insomnia Treatment
Trials in insomnia examine symptom relief in both adolescent and adult psychiatric populations, with attention to persistent sleep disturbance and its impact on mental health.
- Chronic insomnia
- Sleep disturbance in psychiatry
- Adolescent insomnia
Sleep-focused studies include comparisons of melatonin and quetiapine in psychiatric settings.
Psychiatric Disorders with Comorbid Sleep Problems
Broader studies include patients with psychiatric disorders and comorbid chronic insomnia, covering diagnostic groups within ICD-10 F20-F69, F84, and F90-F95.
- Comorbid insomnia in psychiatry
- Augmentation of treatment as usual
- Psychiatric symptom management
This area centers on sleep-related burden across a wide range of mental health conditions treated in specialist care.
